Cancer Patients Current Events | Cancer Patients News | 7
|
| Page
7 of
147 |
2934 Results |
|
|
|
Sort By:
Page Views | Date |
Light therapy could be a new approach to treating patients with pancreatic cancer
Pancreatic cancer is notoriously difficult to treat, largely because of the location of the pancreas close to major arteries and vital organs, and the effects of a poorly functioning pancreas on the rest of the body. It is one of the top 10 leading causes of death from cancer worldwide, and in the UK kills around 6500 people every year. view more (2002-03-11)
Chemotherapy with gemcitabine delays progression of operable pancreatic cancer
Giving pancreatic cancer patients the chemotherapy drug gemcitabine after surgery delays progression of the disease by about six months, according to new research by Japanese scientists. view more (2007-09-27)
Hormone therapy may confer more aggressive properties to prostate tumours
Hormone therapy is often given to patients with advanced prostate cancer. view more (2009-06-11)
Predicting higher risk for prostate cancer diagnosis
High-grade prostatic intraepithelial neoplasia (HGPIN) carries a high predictive value for future diagnosis of prostate cancer. view more (2009-05-27)
Success rates for prostate cancer depend on experience of surgeon
Surgeons performing operations to remove patients' prostate glands-the primary treatment for prostate cancer-go through a steep learning curve, according to a study published online July 24 in the Journal of the National Cancer Institute. view more (2007-07-25)
High-dose vitamin C as a cancer therapy
Although early clinical studies conducted by Linus Pauling showed that high-dose vitamin C, given by intravenous and oral routes, may improve symptoms and prolong life in patients with terminal cancer, no benefits for cancer patients were seen when vitamin C therapy was administered orally in double-blind placebo-controlled studies at the Mayo... view more... (2006-03-28)
Proton therapy lowers chance of later cancers
Patients who are treated with proton therapy (a specialized type of external beam radiation therapy using protons rather than X-rays to treat cancer) decreases the risk of patients developing a secondary cancer by two-fold, compared to being treated with standard photon radiation treatment. view more (2008-09-22)
New study shows way to avoid overtreatment in breast cancer
The numbers of women who receive adjuvant chemotherapy for breast cancer could be reduced by 30 to 40% if the results of a new molecular study are put into practice. Dr Laura van 't Veer from the Netherlands Cancer Institute told the news briefing that micro array technology* can help predict which breast cancers will metastasise (spread) and... view more... (2002-03-20)
CT colonography versus colonoscopy for colorectal cancer
Colorectal cancer is the second leading cause of cancer deaths in most developed countries. view more (2005-10-11)
Fox Chase researchers identify differences in treatments and outcomes of patients with second primary lung cancers versus those with one primary lung cancer
Patients with second primary lung cancers (SPLC), when compared to those with one primary lung cancer (OPLC), are more likely to have localized disease at the time of diagnosis and are more likely to receive surgical treatment rather than radiation treatment. view more (2009-08-03)
Exercise programs may improve symptoms in non-small cell lung cancer patients
Exercise is known to have a positive effect on maintaining a healthy lifestyle, and a study in the May issue of the Journal of Thoracic Oncology has shown that exercise also plays an important role in both primary and secondary prevention of cancer. view more (2009-05-05)
Swiss study finds income affects prostate cancer patients' survival
Prostate cancer patients of low socioeconomic status are more likely to die than patients with higher incomes. view more (2009-09-28)
Pros, cons of drug proven to prevent prostate cancer should be considered, researchers recommend
Findings by UT Southwestern Medical Center researchers encourage men to weigh both the potential benefits and side effects of the drug finasteride before taking it to prevent prostate cancer. view more (2008-01-21)
STUDY LOOKS AT NEEDS OF THOSE ON "DISEASE JOURNEYS"
Member of the research team Dr Scott Murray of the University of Edinburgh's Department of Community Health Sciences said the disease 'journeys' of 25 families with lung cancer and 25 with severe cardiac failure would be followed, through interviews with patients, their relatives and professionals from health and social services. The patients and... view more... (1999-06-21)
Eligibility criteria contribute to racial disparities in hospice use
A new study finds that hospice services-care that is provided by physicians, visiting nurses, chaplains, home health aides, social workers and counselors-have restrictions that reduce usage by many patients who are most in-need, particularly African Americans. view more (2008-12-22)
African-Americans have worse prognosis at colorectal cancer diagnosis
African-American patients with colorectal were more likely to present with worse pathological features at diagnosis and to have a worse five-year survival rate compared to Caucasian patients, according to a study conducted by researchers at Thomas Jefferson University. view more (2009-01-20)
Mesalamine linked to cancer protection for high risk inflammatory bowel disease patients
Researchers found that mesalamine use among patients with inflammatory bowel disease was associated with a decrease in incidence of colorectal cancer when comparing cases and controls. view more (2007-10-15)
More intense bladder cancer treatment does not improve survival, U-M study finds
Despite enduring more invasive tests and medical procedures, patients who were treated aggressively for early stage bladder cancer had no better survival than patients who were treated less aggressively. view more (2009-04-08)
Cancer Survival Rates Higher Than Previously Assumed
Conventional estimates for life expectancy after cancer diagnosis have been too pessimistic, suggests a study in this week's issue of THE LANCET. There are two main ways of quantifying survival estimates after cancer diagnosis. The conventional method, known as the cohort method, is based on the survival experience of cancer patients whose... view more... (2002-10-09)
New prostate cancer marker helps identify men whose cancer is likely to spread
Prostate cancer researchers at Sydney's Garvan Institute, supported by the Cancer Institute NSW, have found a new marker for identifying aggressive prostate cancers. view more (2006-10-04)
|
|
| Page
7 of
147 |
2934 Results |
|
|
|
Sort By:
Page Views | Date |
|
